TAT-GLUA23Y

TAT-GLUA23Y has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 6, 2026: “Postoperative Impairment of GluA2 Ttrafficking in CA3 Induces Memory Consolidation Deficits in Aged Mice by Disrupting SPW-R in CA1”.

Intervention

1 paper studies it1 findingUpdated

More peptides

  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Animals1

What did studies of TAT-GLUA23Y find?

1

Studies of TAT-GLUA23Y measured 1 outcome; the most studied are memory consolidation (1 study).

Memory consolidation

upin mice1

1 study
  1. TAT-GLUA23Y improves memory consolidation in mice.

    “immediate postoperative injection of TAT-GluA23Y into the CA3 region to increase GluA2 synaptic expression significantly ameliorated surgery-induced SPW-R disruption and memory consolidation deficits.”

    AnimalspostoperativeCA3

    Postoperative Impairment of GluA2 Ttrafficking in CA3 Induces Memory Consolidation Deficits in Aged Mice by Disrupting SPW-R in CA1

    Journal of molecular neuroscience : MN

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 paper in 12 months